Evaluation of the prescription pattern of drugs and adherence of physicians to NeuPSIG guidelines in treatment of cancer related neuropathic pain.

Dr Vishal Singh0 个研究点目标入组 291 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Patients of either gender and age above of 18 years and below 80 years experiencing from neuropathic pain due to any cancer.
•2. Patients diagnosed by treating physicians as having neuropathic pain using the screening tool DN4 Neuropathic pain diagnostic questionnaire with score >= 4
•3. Patients willing to give voluntary informed consent.

•1. Patients with established diagnosis of neurogenic pain associated with localized peripheral neuropathies (e.g. Post herpetic neuralgia, Diabetic neuropathy, Post- surgical/traumatic neuropathic pain.)
•2. Patients unable to comprehend the patient information sheet.
•3. Patients diagnosed with fibromyalgia.
•4. Any other medical condition, which in the opinion of the investigator precludes the
•inclusion of the participant.

发起方

Dr Vishal Singh